| 
												  
												
												POST FINASTERIDE SYNDROME (PFS)  
												
												
												TREATMENT
												 
												
												
												
												Aging Diseases provoked by a 
												lack and disruption of androgens 
												production 
												 
												 
												Prevention 
												
												Avoid 5-alpha-reductase 
												inhibitors 
												
												If there is no iatrogenic cause, 
												there will not be an 
												
												
												
												iatrogenic disease. 
												 
												
												Is there a curative treatment for PFS? 
												
												Mesterolone is the right 
												treatment as it is the treatment 
												for the androgenic disease of 
												andropause. 
												
												5-alpha-reductase inhibitors 
												provoke a premature androgenic 
												disease 
												
												The androgenic disease of 
												andropause starts with sexual 
												aging 
												
												Mesterolone doesn't provoke 
												baldness. 
												
												
												
												Clinical research is necessary
												
												
												
												for each man. 
												
												You don't have to look from noon 
												to 2:00 p.m. 
												
												The solution seems to be 
												evident. 
												
												
												5-alpha-reductase inhibitors 
												are not the treatment for 
												baldness 
												
												 
												
												 
												The preventive 
												treatment 
												
												PFS is a problem of production 
												and disruption of androgens' 
												synthesis. 
												
												Suppressing a vital hormone such 
												as dihydrotestosterone with 
												5-alpha-reductase inhibitors 
												causes changes in the 
												entire androgen production chain. 
												
												The diagnosis for each man is 
												unique.  
												
												The 
												PFS sufferer will need a 
												
												
												
												complete checkup
												
												
												of his 
												
												
												
												androgens' biology. 
												
												Treatment is likely to be the 
												opposite 
												of what has been produced by 5-alpha-reductase inhibitors. That is the 
												administration of 
												dihydrotestosterone via the
												
												
												
												
												
												mesterolone,
												
												a safe 
												hormone. Mesterolone has the 
												particularities of both 
												dihydrotestosterone and 
												testosterone. 
												But this must be teached. Furthermore, mesterolone is 
												not available in the US. 
												 
												
												Side effects of PFS 
												can be irreversible. 
												
												
												Prostate atrophy 
												
												 The 
												muscular fibers of the prostate 
												become fibrous under the influence of 5-alpha-reductase inhibitors. In those cases an
												
												
												
												
												endoscopic resection of the 
												fibrous tissue can be necessary. Endoscopic 
												surgery will be followed by 
												correct hormonotherapy. 
												
												
												Nervous breakdown 
												Each man with a nervous 
												breakdown needs a 
												
												
												complete checkup of his 
												androgens. 
												
												Between 1993 and 2020, 
												
												 the 
												iatrogeny 
												has reproduced and aggravated 
												two pathologies :  
												 
												  
												
												
												
												The syndrome of prostate atrophy 
												(1979) 
												
												and 
												
												
												
												The androgenic disease of 
												andropause 
												(1988)  
												
												through the use of 
												
												5-alpha-reductase for illusory 
												and dangerous prescriptions
 
												
 Post-Finasteride Syndrome 
												Foundation
 
 |